Hyperthermia Combined with Chemotherapy – Biological Rationale, Clinical Application, and Treatment Results

@article{Issels1999HyperthermiaCW,
  title={Hyperthermia Combined with Chemotherapy – Biological Rationale, Clinical Application, and Treatment Results},
  author={R. Issels},
  journal={Oncology Research and Treatment},
  year={1999},
  volume={22},
  pages={374 - 381}
}
  • R. Issels
  • Published 1999
  • Medicine
  • Oncology Research and Treatment
There is substantial evidence from preclinical data that the antitumor cytotoxicity of selected chemotherapeutic agents either alone or combined with radiation can be enhanced by appropriate heat exposure (40–44 °C) of cells or tumor tissues. Based upon these results the integration of hyperthermia as an additional treatment modality, given simultaneously with systemic chemotherapy or in combination with radiochemotherapy, is currently tested at the clinic. Regional hyperthermia combined with… Expand
Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future.
TLDR
The review summarizes the outcomes from various clinical studies where hyperthermia is used as a thermal sensitizer of radiotherapy and-/or chemotherapy in various solid tumors and presents an overview of the progresses in loco-regionalhyperthermia. Expand
The cellular and molecular basis of hyperthermia.
TLDR
The direct cytotoxic effect of heat, heat-induced alterations of the tumor microenvironment, synergism of heat in conjunction with radiation and drugs, as well as, the presumed cellular effects of hyperthermia including the expression of heat-shock proteins (HSP), induction and regulation of apoptosis, signal transduction, and modulation of drug resistance byhyperthermia are discussed. Expand
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
TLDR
Hyperthermia along with immune checkpoint inhibitors and DNA damage repair inhibitors could further augment the therapeutic efficacy resulting in synthetic lethality, and could gainfully accomplish a safe, versatile, and cost-effective enhancement of the existing therapeutic armamentarium to improve outcomes in clinical oncology. Expand
A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy.
TLDR
For TSL based chemotherapy, hyperthermia is critical to both increase perfusion and extravasation as well as to trigger TSL drug release, whereby the temperature controlled induction of a local high drug concentration in a highly permeable vessel is driving the enhanced drug uptake in the tumor. Expand
A computational study of combination HIFU-chemotherapy as a potential means of overcoming cancer drug resistance.
TLDR
It is confirmed that hyperthermia can result in less aggressive tumor development and the importance of designing an optimized thermal dose strategy is emphasized, and the results suggest that increasing the length of the on/off cycle of the transducer is an efficient approach to treatment scheduling in the sense of optimizing tumor eradication. Expand
Pegylated Liposomal Doxorubicin in Combination with Hyperthermia for Treatment of Skin Metastases of Breast Carcinoma: A Case Report
TLDR
Present observations suggest that the combination of PLD with hyperthermia of skin metastases of breast carcinoma may be an active and well tolerated treatment. Expand
Current and Potential Role of Thermoradiotherapy for Solid Tumours
TLDR
An ongoing investigation of hyperthermia in multimodal treatment strategies for locally advanced solid tumours is warranted and trials will help to improve temperature monitoring and temperature distribution and define particular groups of patients who will profit from the addition ofhyperthermia. Expand
The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study
TLDR
Radio-frequency regionalhyperthermia in combination with chemotherapy (GP) is a safe, well tolerated, and effective therapeutic modality for patients with advanced NSCLC and the addition of hyperthermia improved quality of life. Expand
Thermoradiotheraphy of cancer: An effective approach
TLDR
An overview on the application of HT combined with conventional cancer treatment modalities, mainly radiotherapy, and results of randomized trials form Western research groups are provided to provide an overview. Expand
Synergistic chemotherapy by combined moderate hyperthermia and photochemical internalization.
TLDR
The combination of PCI and MHT resulted in significant increases in BLM efficacy at 44°C for both cell line derived spheroids compared to controls at 37°C over the range of radiant exposures examined. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
The current and potential role of hyperthermia in radiotherapy.
  • J. Overgaard
  • Medicine
  • International journal of radiation oncology, biology, physics
  • 1989
TLDR
Current clinical experience strongly suggests that hyperthermia will become an important modality as an adjuvant to radiotherapy in the treatment of locally advanced solid tumors, and studies are underway to specifically elucidate the clinical relevance of thermotolerance and other biological issues. Expand
Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study.
TLDR
The study confirms the feasibility of the combination of cisplatin, heat, and radiation with an acceptable toxicity profile in the treatment of superficial cervical nodal metastases from head and neck cancer and the trimodal therapy deserves further evaluation. Expand
Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial.
TLDR
Preoperative HRCT is feasible and effective and may contribute to locoregional tumor control of advanced rectal cancer, which is to be proven in an ongoing phase III trial. Expand
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.
TLDR
It is shown that hyperthermia appears to have an important role in the clinical management of this disease, and there should be no doubt that further studies of the use of this form of treatment are warranted. Expand
Hyperthermo-chemo-radiotherapy for patients with early carcinoma of the esophagus.
TLDR
An accurate diagnosis of the esophageal lesion and appropriate selection of potentially treatable cases are considered essential for the optimal use of HCR therapy in patients with submucosal carcinoma. Expand
Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer.
TLDR
IORT plus EBRT can be recommended for unresectable but localized pancreatic cancer associated with low tumor marker levels and high-dose IORT (30 Gy) + E BRT (40-60 Gy) was more effective than EBRt alone in patients with a CA 19-9 level < 1000 U/ml. Expand
Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment.
TLDR
For regimens of 5 to 10 hyperthermia treatments, improvements in median T90 and T50 parameters could result in response rates high enough to justify Phase III trials, and these values are strongly associated with outcome in multivariate logistic regression analysis. Expand
Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs.
  • M. Kakehi, K. Ueda, +4 authors S. Nakatsugawa
  • Medicine
  • International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • 1990
TLDR
It was indicated that hyperthermia was one of the most effective treatment techniques for advanced or inoperable cases and in improving the quality of life of patients under terminal care. Expand
Molecular and Cellular Mechanisms of Hyperthermia
The success of tumor therapy is determined by the efficiency with which the killing of tumor cells is achieved under conditions of no or only slight damage to the normal tissues. Cell killing in thisExpand
Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus--a prospective randomized trial.
  • K. Sugimachi, K. Kitamura, +4 authors H. Kuwano
  • Medicine
  • International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • 1992
TLDR
It is suggested that preoperative HCR therapy may be a more beneficial therapy than preoperative CR therapy in patients with squamous cell carcinoma of the oesophagus who undergo a subtotal oesphagectomy. Expand
...
1
2
3
4
5
...